96.  Day, N., Yokoyama, K., and Ichiki, A. T. “Alternative splicing of the K-562 CIITA introduces a stop codon, resulting in an inactive protein”, XV Meeting of the International Society of Hematology European & African Division, Cairo, pp.14, Egypt, Oct.(2001).

97.  Yokoyama, K.: “P300 and ATF-2 facilitate transcription of c-jun gene during retinoic acid (RA)-induced differentiation of embryonal carcinoma” American Chemical Society 221^st National Meeting,  pp.22, San Diego, pp.22, CA, April (2001).

98.  Murata, T., Nagaso, H., Yokoyama, K.: “hiiragi involved in the wing formation of Drosophila encodes a poly (A) polymerase”. 14^th International Congress of Developmental Biology, pp.100, Kyoto, July (2001).

99.  Murata, T., Nagaso, H., Kashiwabara, S., Baba, T., Yokoyama, K.: “Enzymatic activity of Poly (A) polymerase is required to reverse the mutant phenotype of hiiragi”.  Eukaryotic mRNA Processing, Cold Spring Harbor, pp.35, NY, Aug. (2001).

100.  Yokoyama, K., Jin, C., Li, H., Taira, K., and Kawasaki, H.: “AP-1 repressor protein JDP-2 inhibits the transactivation of c-jun gene facilitated by p300 and ATF-2 or retinoic acid (RA) mediated differentiation of F9 cells” Mechanisms of Eukaryotic Transcription, Cold Spring Harbor, pp.332, NY, Aug. (2001).

101.  Day, N., Ichiki, A. T., and Yokoyama, K.: “Alterative splicing of the K-562 CIITA introduces a step codon, resulting in an inactive protein”.  10^th International Symposium on Molecular Cell Biology of Macrophages 2001, pp.79, Tokyo, June (2001).

102.  Jin, C., Li, H., and Yokoyama, K.: “Jun dimerization protein 2 interacts with ATF-2 and represses the differentiation of F9 cells induced by retinoic acid” 14^th International Congress of Developmental Biology,  Kyoto, pp.147, July (2001).

103.  Fukuda, K., Abei, M., Ugai, H., Seo, E., Todoroki, T., Hamada, H., Yokoyama, K., Tanaka, N.: “Gene therapy for gallbladder cancer using replication-competent E1 mutant adenovirus vectors” 5^th World Congress of the International Hepato-Pancreato-Biliary Association, Tokyo, pp.107,April (2002).

104.  Yokoyama, K: “Recombinant adenovirus vector for safety use to introduce the gene” Oligonucleotide and Peptide Technology Conference 2002, Las Vegas, May, pp.626 (2002).

105.  Fukuda, K., Abei, M., Ugai, H., Yokoyama, K.: ”Experimental gene therapy using tumor-specific replicating adenovirus vectors” Digestive Disease Week-2002, San Francisco, pp. May (2002).

106.  Yokoyama, K., Song, J., Jin, C., Li, H., Ugai, H. and Murata, T.: “Regulation of the transcription of a housekeeping gene by two different zinc-finger proteins” Cancer Genetics , Cold Spring Harbor Meeting, Cold Spring Harbor, NY, pp.272, Aug. (2002).

107.  Kishikawa, S., Murata, T. and Yokoyama, K.: “Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins Dynamic Organization of Nuclear Function.”  Cold Spring Harbor Meeting, Cold Spring Harbor, NY, pp.129, Sept. (2002).

108.  Kishikawa, S. and Yokoyama, K.: “Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.”  11^th International Symposium on Molecular Cell Biology of Macrophage 2002, Niigata, pp.80, June (2002).

109.  Jin, C., Li, H., and Yokoyama, K.: “Role of a repressor of Ap-1, JDP2, in the control of retinoic acid-induced differentiation of F9 cells” Cancer Genetics & Tumor suppressor Genes Cold Spring Harbor Meeting, Cold Spring Harbor, NY, pp.105, Aug. (2002).

>>top